J. Munkhaugen

发表

Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease

Lars Aastebøl Frøjd, T. Dammen, J. Munkhaugen, 2022, Sleep advances : a journal of the Sleep Research Society.

Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial

Morten Wang Fagerland, T. Dammen, J. Munkhaugen, 2020, European heart journal. Cardiovascular pharmacotherapy.

Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study

T. Dammen, J. Munkhaugen, J. Hjelmesæth, 2018, BMC Cardiovascular Disorders.

BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study

Morten Wang Fagerland, D. Atar, H. Schirmer, 2019, American heart journal.

The role of medical and psychosocial factors for unfavourable coronary risk factor control

T. Dammen, J. Munkhaugen, E. Sverre, 2016, Scandinavian cardiovascular journal : SCJ.

Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction

T. Edvardsen, J. Munkhaugen, O. Klungsøyr, 2021, The International Journal of Cardiovascular Imaging.

Shared genetic loci between depression and cardiometabolic traits

S. Djurovic, O. Andreassen, T. Dammen, 2022, PLoS genetics.

The role of cardiac rehabilitation in secondary prevention after coronary events

T. Dammen, J. Munkhaugen, T. Moum, 2017, European journal of preventive cardiology.

Monitoring Simvastatin Adherence in Patients With Coronary Heart Disease: A Proof-of-Concept Study Based on Pharmacokinetic Measurements in Blood Plasma

J. Munkhaugen, S. Bergan, E. Husebye, 2022, Therapeutic drug monitoring.

Is the evidence base for post-myocardial infarction beta-blockers outdated?

J. Munkhaugen, D. Thelle, J. Otterstad, 2016, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

The Attention Training Technique Reduces Anxiety and Depression in Patients With Coronary Heart Disease: A Pilot Feasibility Study

T. Dammen, J. Munkhaugen, C. Papageorgiou, 2022, Frontiers in Psychology.

New aspects of pre-eclampsia: lessons for the nephrologist.

J. Munkhaugen, B. Vikse, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Relationships between depression, anxiety, type D personality, and worry and rumination in patients with coronary heart disease

T. Dammen, J. Munkhaugen, C. Papageorgiou, 2022, Frontiers in Psychology.

Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting

D. Atar, J. Munkhaugen, S. Halvorsen, 2022, BMC Health Services Research.

Unfavourable risk factor control after coronary events in routine clinical practice

T. Dammen, J. Munkhaugen, E. Sverre, 2017, BMC Cardiovascular Disorders.

The follow-up after myocardial infarction - is it good enough?

T. Dammen, J. Munkhaugen, E. Sverre, 2018, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?

J. Munkhaugen, E. Sverre, L. Gullestad, 2020, European journal of preventive cardiology.

Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs

J. Munkhaugen, S. Halvorsen, H. Støvring, 2022, European heart journal open.

Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self‐perceived muscle side effects

T. Dammen, J. Munkhaugen, E. Sverre, 2022, Journal of internal medicine.

Shared genetic architecture between neuroticism, coronary artery disease and cardiovascular risk factors

S. Djurovic, O. Andreassen, T. Dammen, 2021, Translational Psychiatry.

A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease

Morten Wang Fagerland, J. Munkhaugen, S. Bergan, 2019, British journal of clinical pharmacology.

Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients

T. Dammen, J. Munkhaugen, E. Sverre, 2017, European journal of preventive cardiology.

Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis

T. Edvardsen, J. Munkhaugen, J. Otterstad, 2017, European journal of preventive cardiology.

Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.

S. Lydersen, S. Hallan, J. Munkhaugen, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway.

S. Lydersen, P. Romundstad, S. Hallan, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study

T. Dammen, J. Munkhaugen, H. Lie, 2023, Frontiers in Psychology.

Blood pressure reference values in adolescents: methodological aspects and suggestions for Northern Europe tables based on the Nord-Trøndelag Health Study II

S. Lydersen, S. Hallan, J. Munkhaugen, 2008, Journal of hypertension.

Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis

D. Atar, C. Gale, J. Munkhaugen, 2018, European heart journal. Cardiovascular pharmacotherapy.

Optimal blood pressure control after coronary events: the challenge remains.

T. Dammen, J. Munkhaugen, E. Sverre, 2017, Journal of the American Society of Hypertension : JASH.

A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry

J. Munkhaugen, S. Bergan, E. Husebye, 2019, Therapeutic drug monitoring.

The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event

T. Dammen, J. Munkhaugen, T. Moum, 2018, European journal of preventive cardiology.

Medical and sociodemographic factors predict persistent smoking after coronary events

T. Dammen, J. Munkhaugen, E. Sverre, 2017, BMC Cardiovascular Disorders.

Reproducibility of an extensive self-report questionnaire used in secondary coronary prevention

T. Dammen, J. Munkhaugen, T. Moum, 2017, Scandinavian journal of public health.

Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin‐Associated Muscle Symptoms

J. Munkhaugen, E. Sverre, S. Bergan, 2023, Clinical pharmacology and therapeutics.

Statin-associated muscle symptoms in coronary patients: design of a randomized study

Morten Wang Fagerland, T. Dammen, J. Munkhaugen, 2019, Scandinavian cardiovascular journal : SCJ.

Patient characteristics and risk factors of participants and non-participants in the NOR-COR study

T. Dammen, J. Munkhaugen, E. Sverre, 2016, Scandinavian cardiovascular journal : SCJ.

Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population

T. Dammen, J. Munkhaugen, H. Weedon-Fekjær, 2020, BMC Cardiovascular Disorders.

The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.

Morten Wang Fagerland, T. Dammen, J. Munkhaugen, 2021, Atherosclerosis.

Medical and Psychosocial Factors Associated With Low Physical Activity and Increasing Exercise Level After a Coronary Event

T. Dammen, J. Munkhaugen, E. Sverre, 2020, Journal of cardiopulmonary rehabilitation and prevention.

Challenges in coronary heart disease prevention – experiences from a long-term follow-up study in Norway

T. Dammen, J. Munkhaugen, E. Sverre, 2020, Scandinavian cardiovascular journal : SCJ.

Predictors of health-related quality of life in outpatients with coronary heart disease

T. Dammen, J. Munkhaugen, C. Papageorgiou, 2023, Frontiers in Psychology.

Insomnia in patients with coronary heart disease: prevalence and correlates.

T. Dammen, J. Munkhaugen, I. Nordhus, 2021, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Risk of recurrent cardiovascular events in coronary artery disease patients with Type D personality

O. Andreassen, T. Dammen, J. Munkhaugen, 2023, Frontiers in Psychology.

Psychiatric disorders, rumination, and metacognitions in patients with type D personality and coronary heart disease

T. Dammen, J. Munkhaugen, C. Papageorgiou, 2023, Nordic journal of psychiatry.

Effect of oral b -blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis

D. Atar, C. Gale, J. Munkhaugen, 2018 .

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease

J. Munkhaugen, E. Sverre, S. Bergan, 2023, Pharmacology research & perspectives.

Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects

T. Dammen, J. Munkhaugen, E. Sverre, 2021, BMC Cardiovascular Disorders.

Attention training technique delivered in groups as treatment for anxiety and depression in patients with coronary heart disease: study protocol for a waiting-list randomized controlled trial

T. Dammen, J. Munkhaugen, C. Papageorgiou, 2023, Frontiers in psychology.

Editorial: Progress in understanding and treating distress, sleep, and personality in heart and lung disease

T. Dammen, J. Munkhaugen, C. Papageorgiou, 2023, Frontiers in psychology.

Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.

T. Dammen, J. Munkhaugen, E. Sverre, 2024, Atherosclerosis.